Nuvation Bio rises as Cantor initiates at overweight
Reported by Seeking Alpha · seekingalpha.com · August 21, 2026
Cantor initiates Nuvation Bio at overweight, citing undervalued Ibtrozi and safusidenib upside. Read more here.
What the tape says
What to watch: Potential opportunity in Markets — evaluate fundamentals before acting.
Market reaction today: $NUVB -2.45%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.